Associate Professor of Medicine, Massachusetts General Hospital
Endocrinology
Dr. Enrico Cagliero, MD
|
|
Give Review
Doctor Enrico Cagliero, MD works in the field of Endocrinology. Enrico Cagliero is also a published physician. He has 81 paper published. The most recent paper is: Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication. Enrico Cagliero accepts Medicare payments and is listed with Medicare.gov.
Publications
- A Distributed Model: Redefining a Robust Research Subject Advocacy Program at the Harvard Clinical and Translational Science Center.
- A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 Diabetes.
- Pathways to quality inpatient management of hyperglycemia and Diabetes: a call to action.
- Validity of medication adherence self-reports in adults with type 2 Diabetes.
- Impact of inpatient Diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.
- Musculoskeletal disorders of the hand and shoulder in patients with Diabetes mellitus.
- Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 Diabetes.
- A controlled trial of web-based Diabetes disease management: the MGH Diabetes primary care improvement project.
- Rheumatic manifestations of Diabetes mellitus.
- Impact of population management with direct physician feedback on care of patients with type 2 Diabetes.
- Health care resource utilization associated with a Diabetes center and a general medicine clinic.
- Glucose metabolism in patients With schizophrenia treated With atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model...
- Sex disparities in treatment of cardiac risk factors in patients with type 2 Diabetes.
- Internet use among primary care patients with type 2 Diabetes: the generation and education gap.
- Glucose metabolism in patients With schizophrenia treated With olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model anal...
- Treatment of cardiac risk factors among patients with schizophrenia and Diabetes.
- International trial of the Edmonton protocol for islet transplantation.
- Prevalence of hyper- and hypoglycemia among inpatients with Diabetes: a national survey of 44 U.S. hospitals.
- How doctors choose medications to treat type 2 Diabetes: a national survey of specialists and academic generalists.
- Elevated hemoglobin A1c as a possible indicator of Diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
- Depression, self-care, and medication adherence in type 2 Diabetes: relationships across the full range of symptom severity.
- Case records of the Massachusetts General Hospital. Case 21-2007. A 58-year-old woman With headaches, weakness, and strokelike episodes.
- Inpatient Diabetes management in non-ICU settings: evidence and strategies.
- Measuring psychological insulin resistance: barriers to insulin use.
- Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed Diabetes in the US population.
- Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.
- Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of Diabetes.
- Point-of-care glucose and hemoglobin A1c in emergency department patients without known Diabetes: implications for opportunistic screening.
- A controlled trial of population management: Diabetes mellitus: putting evidence into practice (DM-PEP).
- Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 Diabetes mellitus randomized to rosiglitazone or placebo.
- Effectiveness of a computerized insulin order template in general medical inpatients with type 2 Diabetes: a cluster randomized trial.
- How much do you know about peripheral arterial disease?
- Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
- Symptoms of depression prospectively predict poorer self-care in patients with Type 2 Diabetes.
- Retinal haemodynamics in individuals with well-controlled type 1 Diabetes.
- The incremental costs of recommended therapy versus real world therapy in type 2 Diabetes patients.
- Association of Diabetes-related emotional distress with Diabetes treatment in primary care patients with Type 2 Diabetes.
- Correlates of health-related quality of life in type 2 Diabetes.
- Clinical inertia in the management of Type 2 Diabetes metabolic risk factors.
- Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages.
- Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets.
- Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.
- Measurement of gene expression in human retinal microvessels by solution hybridization.
- Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP.
- Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells.
- Pathobiology of endothelial and other vascular cells in Diabetes mellitus. Call for data.
- Overexpression of fibronectin induced by Diabetes or high glucose: phenomenon with a memory.
- Modification of tissue-factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells.
- Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man.
- Diabetes-induced changes of proteins synthesized by adult cardiac myocytes are partially reversed by insulin.
- Increased expression of basement membrane components in human endothelial cells cultured in high glucose.
- The corticotropin-releasing factor test in the diagnosis of ectopic ACTH secretion.
- Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death.
- Racial differences in incidence of juvenile-onset type 1 Diabetes: epidemiologic studies in southern California.
- Influence of glucagon on plasma levels of potassium in man.
- Glucagon-induced increase in plasma potassium levels in Type 1 (insulin-dependent) diabetic subjects.
- Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation With clonidine.
- A study of platelet-relevant parameters in patients With diabetic microangiopathy.
- Reduced glucose tolerance after guanfacine in normal and obese subjects.
- Interaction of human endothelial cells With elevated glucose concentrations and native and glycosylated low density lipoproteins.
- Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?
- Glucagon induced hyperkalemia in Diabetes.
- The hypophosphatemic and hyperkalemic effect of arginine in man.
- Increased platelet volume in diabetic retinopathy.
- Absence of alterations in plasma levels of various hypophyseal hormones after administration of cytidine-diphosphate-coline.
- The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject.
- The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta.
- Activity and expression of the Na+/H+ exchanger in human endothelial cells cultured in high glucose.
- Maternal Diabetes induces increased expression of extracellular matrix components in rat embryos.
- Vascular wall von Willebrand factor in human diabetic retinopathy.
- Genotoxic agents increase expression of growth arrest and DNA damage--inducible genes gadd 153 and gadd 45 in rat pancreatic islets.
- Fibronectin overexpression in retinal microvessels of patients with Diabetes.
- Altered levels of scavenging enzymes in embryos subjected to a diabetic environment.
- Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication.
- Immediate feedback of HbA1c levels improves glycemic control in Type 1 and insulin-treated Type 2 diabetic patients.
- MET oncogene aberrant expression in canine osteosarcoma.
- Clozapine, Diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
- Megestrol-induced clinical adRenal insufficiency.
- The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors.
- Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 Diabetes mellitus.
Schools
University of Torino Faculty of Medicine And Surgery
University Calif
Massachusetts General Hospital
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Hyperkalemia
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of California San Diego -
University of Torino Faculty of Medicine
Hospital
-
Newton-Wellesley Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1700877347 | |
| NPPES Provider LastName | CAGLIERO | |
| NPPES Provider FirstName | ENRICO | |
| NPPES Provider ZIPCode | 021142517 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1313.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700877347 |
| Last Name Of The Provider | CAGLIERO |
| First Name Of The Provider | ENRICO |
| View All |
Similar Doctors
|
|
Dr. Corrine K. Welt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravikumar Balasubramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily D. Szmuilowicz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karla M. Pou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shanti Serdy, MD
This Doctor is OpenDoctor Recommended.
|